Scorpius Holdings, Inc. (SCPX)

USD 0.12

(-8.93%)

Long Term Debt Summary of Scorpius Holdings, Inc.

  • Scorpius Holdings, Inc.'s latest annual long term debt in 2023 was 12.61 Million USD , up 46.67% from previous year.
  • Scorpius Holdings, Inc.'s latest quarterly long term debt in 2024 Q2 was 1.94 Million USD , down 0.0% from previous quarter.
  • Scorpius Holdings, Inc. reported annual long term debt of 8.59 Million USD in 2022, up 553.35% from previous year.
  • Scorpius Holdings, Inc. reported annual long term debt of 1.31 Million USD in 2021, down -9.96% from previous year.
  • Scorpius Holdings, Inc. reported quarterly long term debt of 1.94 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Scorpius Holdings, Inc. reported quarterly long term debt of 8.46 Million USD for 2023 Q1, down -1.55% from previous quarter.

Annual Long Term Debt Chart of Scorpius Holdings, Inc. (2023 - 2015)

Historical Annual Long Term Debt of Scorpius Holdings, Inc. (2023 - 2015)

Year Long Term Debt Long Term Debt Growth
2023 12.61 Million USD 46.67%
2022 8.59 Million USD 553.35%
2021 1.31 Million USD -9.96%
2020 1.46 Million USD -12.05%
2019 1.66 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 3.61 Million USD 0.0%

Peer Long Term Debt Comparison of Scorpius Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD -2448.112%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Armata Pharmaceuticals, Inc. 82.3 Million USD 84.675%
Actinium Pharmaceuticals, Inc. 1.57 Million USD -702.363%
Azitra, Inc. 563.69 Thousand USD -2137.597%
Can-Fite BioPharma Ltd. 13 Thousand USD -96924.262%
Chromocell Therapeutics Corporation - USD -Infinity%
Calidi Biotherapeutics, Inc. 2.06 Million USD -512.289%
CEL-SCI Corporation 11.6 Million USD -8.711%
iBio, Inc. 3.5 Million USD -259.657%
Lineage Cell Therapeutics, Inc. 2.07 Million USD -509.331%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 2.89 Million USD -335.688%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD -573.882%
NovaBay Pharmaceuticals, Inc. 1.1 Million USD -1038.371%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. - USD -Infinity%
BiomX Inc. 5.4 Million USD -133.49%
BiomX Inc. 5.4 Million USD -133.49%
Protalix BioTherapeutics, Inc. 4.62 Million USD -172.953%
Palatin Technologies, Inc. 163.78 Thousand USD -7601.185%
Theriva Biologics, Inc. 162 Thousand USD -7685.898%